Vimarsana
Biggest News Aggregation in the World

Keisuke Ejima News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Keisuke Ejima. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Keisuke Ejima Today - Breaking & Trending Today

New Study Highlights Underlying Flaws In COVID-19 Antiviral Drug Clinical Trials - Vimarsana News

New Study Highlights Underlying Flaws In COVID-19 Antiviral Drug Clinical Trials

Credit Justin Hicks / IPB News Clinical trials for antiviral drugs to treat COVID-19 have produced inconsistent results. New research led by Indiana University says the problem may come down to how these trials are designed.  Indiana University assistant research scientist Keisuke Ejima and researchers at Nagoya University in Aichi, Japan, created simulations based on clinical data to analyze how COVID-19 drug trials are designed.  To best decrease the viral load, or the amount of virus in a person, the study found participants needed antiviral medication within two days of developing sympt...

Source: wboi.org
New Study Highlights Underlying Flaws In COVID-19 Antiviral Drug Clinical Trials - Vimarsana News

New Study Highlights Underlying Flaws In COVID-19 Antiviral Drug Clinical Trials

New Study Highlights Underlying Flaws In COVID-19 Antiviral Drug Clinical Trials Unable to load the audio player. playpausemuteunmute Article origination IPBS-RJC To best decrease the viral load, or the amount of virus in a person, the study found participants needed antiviral medication within two days of developing symptoms. Justin Hicks/IPB News Clinical trials for antiviral drugs to treat COVID-19 have produced inconsistent results. New research led by Indiana University says the problem may come down to how these trials are designed.  Indiana University assistant research scientist K...

Source: wfyi.org
Study reveals contributing factor to inconsistent results in clinical trials for COVID-19 drugs - Vimarsana News

Study reveals contributing factor to inconsistent results in clinical trials for COVID-19 drugs

Study reveals contributing factor to inconsistent results in clinical trials for COVID-19 drugs Jul 8 2021 A new study suggests that significant variation in the amount of virus from person to person may be a contributing factor to inconsistent findings reported in clinical trials for antiviral COVID-19 drugs. The study is led by Keisuke Ejima, an assistant research scientist at the Indiana University School of Public Health-Bloomington. A new study suggests that significant variation in the amount of virus from person to person may be a contributing factor to inconsistent findings reported i...

$2.9 million NIH grant will help IU researcher expand work on subconcussive impacts - Vimarsana News

$2.9 million NIH grant will help IU researcher expand work on subconcussive impacts

 E-Mail Every year, nearly 2.5 million U.S. high school athletes participate in contact sports. Each of these athletes sustains an average of 650 subconcussive head impacts in a single season, hits that can negatively affect brain health. A $2.9 million grant from the National Institutes of Health will help researchers at Indiana University determine whether, and to what extent, repetitive subconcussive head impacts -- impacts that do not trigger clinically detectable signs and symptoms of concussion -- negatively affect brain health in adolescents. If applied repeatedly, subconcussive impac...